@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_head { this: np:hasAssertion dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_assertion; np:hasProvenance dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_provenance; np:hasPublicationInfo dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_publicationInfo; a np:Nanopublication . dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_assertion a np:Assertion . dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_provenance a np:Provenance . dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_publicationInfo a np:PublicationInfo . } dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_assertion { miriam-gene:4580 a ncit:C16612 . lld:C0023418 a ncit:C7057 . dgn-gda:DGNd3b8f2198f0e3354b5dd9c5341df20e9 sio:SIO_000628 miriam-gene:4580, lld:C0023418; a sio:SIO_001121 . } dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_provenance { dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_assertion dcterms:description "[The human leukemia cell lines NALM6 (B-lineage) and CCRF/CEM (T-lineage) were used to assess potential mechanisms for these lineage differences in MTX accumulation, revealing i) greater total and long-chain MTXPG accumulation in NALM6 over a wide range of methotrexate concentrations (0.2-100 microM), ii) saturation of MTXPG accumulation in both cell lines, with a higher maximum (Emax in NALM6, iii) 3-fold higher constitutive FPGS mRNA expression and enzyme activity in NALM6 cells, iv) 2-fold lower levels of DHFR mRNA and protein in NALM6 cells, and v) 4-6 fold lower extracellular MTX concentration and 2-fold lower intracellular MTXPG concentration to produce equivalent cytotoxicity (LC50) in NALM6 versus CEM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:9224825; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP577933.RAmSJlS5ahO-pgjMGnSEjQpiHHdTJL58a0n8ynQRX-nFs130_publicationInfo { this: dcterms:created "2015-08-25T14:43:24+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }